On March 13, 2023 MAIA Biotechnology, Inc. (NYSE American: MAIA) reported the Company has no exposure to Silicon Valley Bank ("SVB"). The Company is aware that the Federal Deposit Insurance Corp. has taken control of SVB due to liquidity concerns (Press release, MAIA Biotechnology, MAR 13, 2023, View Source [SID1234628610]). The Company confirms it does not hold any deposits or investments at SVB, as well as at Silvergate Bank, or Signature Bank. MAIA’s cash is managed across a top-tier financial institution.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!